Dafna Capital Management LLC Zymeworks Inc. Transaction History

Dafna Capital Management LLC

  • $389 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$39.12 - $54.99 $389,244 - $547,150
-9,950 Closed
0 $0
Q3 2020

Nov 16, 2020
SELL
$29.21 - $46.58 $236,279 - $376,785
-8,089 Reduced 44.84%
9,950 $463,000
Q2 2020

Aug 14, 2020
SELL
$33.67 - $40.0 $470,066 - $558,440
-13,961 Reduced 43.63%
18,039 $651,000
Q1 2020

May 15, 2020
BUY
$24.28 - $49.8 $776,960 - $1.59 Million
32,000 New
32,000 $1.14 Million

Others Institutions Holding ZYME

# of Institutions
1
Shares Held
296K
Call Options Held
0
Put Options Held
0
View Full List

About Zymeworks Inc.

ZYME Quotes by TradingView
  • Ticker ZYME
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,694,400
  • Market Cap $875M
  • Description
  • Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...
More about ZYME
Track This Portfolio

Track Dafna Capital Management LLC Portfolio

Follow Dafna Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email